Efficacy of Palivizumab Prophylaxis Among Infants With Congenital Heart Disease: A Case Control Study

MODERN POTENTIALITIES OF IMMUNOPROPHYLAXIS OF SEVERE COURSE OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH THE CONSEQUENCES OF PERINATAL PATHOLOGY

L.S. Namazova-Baranova
I.V. Davydova
T.V. Turti
I.A. Belyaeva
V.V. Altunin

August 2011

To a risk group of a heavy course of the respiratory syncytial viral (RSV) infection could be ascrib...

A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

Hsin Chi
Chyong-Hsin Hsu
Jui-Hsing Chang
Nan-Chang Chiu
Han-Yang Hung
Hsin-An Kao
Li-Chuan Weng
Fu-Yuan Huang
Yu-Ying Chiu
Luan-Yin Chang
Li-Min Huang

Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly d...

Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab

Manzoni, Paolo
Baraldi, Eugenio
Luna, Manuel Sánchez
Tzialla, Chryssoula

January 2022

Objective This article aims to assess the real-world effectiveness of palivizumab immunoprophylaxis ...

Efficacy of Palivizumab Prophylaxis Among Infants With Congenital Heart Disease: A Case Control Study

Argun, Mustafa
Ozyurt, Abdullah
PAMUKÇU, Özge
ZARARSIZ, Gökmen
BAYKAN, Ali
ÜZÜM, Kazım
SUNKAK, Süleyman
NARİN, Nazmi

October 2015

Background: Palivizumab prophylaxis for RSV has been consistently reported to reduce the risk of hos...

Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study

Chiara Ratti
Anna della Greca
Deborah Bertoncelli
Monica Rubini
Bertrand Tchana

January 2023

Abstract Background In children with congenital heart disease (CHD) respiratory syncytial virus (RSV...

Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease

Chang, Ruey-Kang R.
Chen, Alex Y.

January 2010

The objective of this study was to evaluate the impact of palivizumab prophylaxis on respiratory syn...

Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective.

Homaira, N
Rawlinson, W
Snelling, TL
Jaffe, A

January 2014

Infection with respiratory syncytial virus (RSV) is one of the major causes globally of childhood re...

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease

Feltes, Timothy F
Sondheimer, Henry M
Tulloh, Robert MR
Harris, Brian S
Jensen, Kathryn M
Losonsky, Genevieve A
Griffin, M Pamela
Motavizumab Cardiac Study Group, the
De Wolf, Daniël

January 2011

Children with hemodynamically significant congenital heart disease (CHD) are at risk for serious res...

A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation

Turti Tatyana V
Baibarina Elena N
Degtiareva Elena A
Keshishyan Elena S
Lobzin Yurii V
Namazova-Вaranova Leyla S
Prodeus Andrey P
Gudkov Konstantin M
Kruglova Anna I
Schulz Gregory A
Notario Gerard F

September 2012

Abstract Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract ...

Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study

M. Elhalik
K. El-Atawi
S.K. Dash
A. Faquih
A.D. Satyan
N. Gourshettiwar
A. Khan
S. Varughese
A. Ramesh
E. Khamis

January 2019

Background. Respiratory syncytial virus (RSV) represents a significant public health burden and the ...

Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease

Granbom, Elin
Fernlund, Eva
Sunnegardh, Jan
Lundell, Bo
Naumburg, Estelle

January 2014

Aim: This is the first study to evaluate compliance with the 2003 Swedish national guidelines for pr...

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

Suada Heljic
Hajrija Maksic
Hidajeta Begic
Fahrija Skokic
Darinka Glamuzina
Tomica Bozic
Stojislav Konjevic
Veroslava Milosevic
Sabina Terzic

February 2016

Background: Palivizumab is indicated for respiratory syncytial virus (RSV) proph...

Respiratory syncytial virus infection in children with congenital heart defects: Problem relevance and prevention guidelines

E. L. Bockeria
E. A. Degtyareva
I. A. Kovalev
I. G. Soldatova

January 2014

Congenital heart defects in children are the most important problem in neonatology and pediatrics...

Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain

Ralph Schmidt
Istvan Majer
Natalia García Román
Alejandra Rivas Basterra
ElizaBeth Grubb
Constancio Medrano López

December 2017

Abstract Background Respiratory syncytial virus (RSV) infection remains one of the major reasons of ...

Respiratory Syncytial Immunoprophylaxis with Palivizumab

De Halleux, Virginie
Lombet, Jacques
Rigo, Jacques

January 2007

peer reviewedRespiratory syncytial virus (RSV) is a serious pathogen causing significant morbidity, ...

MODERN POTENTIALITIES OF IMMUNOPROPHYLAXIS OF SEVERE COURSE OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH THE CONSEQUENCES OF PERINATAL PATHOLOGY

L.S. Namazova-Baranova
I.V. Davydova
T.V. Turti
I.A. Belyaeva
V.V. Altunin

August 2011

To a risk group of a heavy course of the respiratory syncytial viral (RSV) infection could be ascrib...

A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

Hsin Chi
Chyong-Hsin Hsu
Jui-Hsing Chang
Nan-Chang Chiu
Han-Yang Hung
Hsin-An Kao
Li-Chuan Weng
Fu-Yuan Huang
Yu-Ying Chiu
Luan-Yin Chang
Li-Min Huang

Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly d...

Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab

Manzoni, Paolo
Baraldi, Eugenio
Luna, Manuel Sánchez
Tzialla, Chryssoula

January 2022

Objective This article aims to assess the real-world effectiveness of palivizumab immunoprophylaxis ...

Efficacy of Palivizumab Prophylaxis Among Infants With Congenital Heart Disease: A Case Control Study

Argun, Mustafa
Ozyurt, Abdullah
PAMUKÇU, Özge
ZARARSIZ, Gökmen
BAYKAN, Ali
ÜZÜM, Kazım
SUNKAK, Süleyman
NARİN, Nazmi

October 2015

Background: Palivizumab prophylaxis for RSV has been consistently reported to reduce the risk of hos...

Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study

Chiara Ratti
Anna della Greca
Deborah Bertoncelli
Monica Rubini
Bertrand Tchana

January 2023

Abstract Background In children with congenital heart disease (CHD) respiratory syncytial virus (RSV...

Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease

Chang, Ruey-Kang R.
Chen, Alex Y.

January 2010

The objective of this study was to evaluate the impact of palivizumab prophylaxis on respiratory syn...

Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective.

Homaira, N
Rawlinson, W
Snelling, TL
Jaffe, A

January 2014

Infection with respiratory syncytial virus (RSV) is one of the major causes globally of childhood re...

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease

Feltes, Timothy F
Sondheimer, Henry M
Tulloh, Robert MR
Harris, Brian S
Jensen, Kathryn M
Losonsky, Genevieve A
Griffin, M Pamela
Motavizumab Cardiac Study Group, the
De Wolf, Daniël

January 2011

Children with hemodynamically significant congenital heart disease (CHD) are at risk for serious res...

A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation

Turti Tatyana V
Baibarina Elena N
Degtiareva Elena A
Keshishyan Elena S
Lobzin Yurii V
Namazova-Вaranova Leyla S
Prodeus Andrey P
Gudkov Konstantin M
Kruglova Anna I
Schulz Gregory A
Notario Gerard F

September 2012

Abstract Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract ...

Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study

M. Elhalik
K. El-Atawi
S.K. Dash
A. Faquih
A.D. Satyan
N. Gourshettiwar
A. Khan
S. Varughese
A. Ramesh
E. Khamis

January 2019

Background. Respiratory syncytial virus (RSV) represents a significant public health burden and the ...

Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease

Granbom, Elin
Fernlund, Eva
Sunnegardh, Jan
Lundell, Bo
Naumburg, Estelle

January 2014

Aim: This is the first study to evaluate compliance with the 2003 Swedish national guidelines for pr...

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

Suada Heljic
Hajrija Maksic
Hidajeta Begic
Fahrija Skokic
Darinka Glamuzina
Tomica Bozic
Stojislav Konjevic
Veroslava Milosevic
Sabina Terzic

February 2016

Background: Palivizumab is indicated for respiratory syncytial virus (RSV) proph...

Respiratory syncytial virus infection in children with congenital heart defects: Problem relevance and prevention guidelines

E. L. Bockeria
E. A. Degtyareva
I. A. Kovalev
I. G. Soldatova

January 2014

Congenital heart defects in children are the most important problem in neonatology and pediatrics...

Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain

Ralph Schmidt
Istvan Majer
Natalia García Román
Alejandra Rivas Basterra
ElizaBeth Grubb
Constancio Medrano López

December 2017

Abstract Background Respiratory syncytial virus (RSV) infection remains one of the major reasons of ...

Respiratory Syncytial Immunoprophylaxis with Palivizumab

De Halleux, Virginie
Lombet, Jacques
Rigo, Jacques

January 2007

peer reviewedRespiratory syncytial virus (RSV) is a serious pathogen causing significant morbidity, ...

MODERN POTENTIALITIES OF IMMUNOPROPHYLAXIS OF SEVERE COURSE OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH THE CONSEQUENCES OF PERINATAL PATHOLOGY

L.S. Namazova-Baranova
I.V. Davydova
T.V. Turti
I.A. Belyaeva
V.V. Altunin

August 2011

To a risk group of a heavy course of the respiratory syncytial viral (RSV) infection could be ascrib...

A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

Hsin Chi
Chyong-Hsin Hsu
Jui-Hsing Chang
Nan-Chang Chiu
Han-Yang Hung
Hsin-An Kao
Li-Chuan Weng
Fu-Yuan Huang
Yu-Ying Chiu
Luan-Yin Chang
Li-Min Huang

Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly d...

Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab

Manzoni, Paolo
Baraldi, Eugenio
Luna, Manuel Sánchez
Tzialla, Chryssoula

January 2022

Objective This article aims to assess the real-world effectiveness of palivizumab immunoprophylaxis ...

Efficacy of Palivizumab Prophylaxis Among Infants With Congenital Heart Disease: A Case Control Study

Abstract

Extracted data

Efficacy of Palivizumab Prophylaxis Among Infants With Congenital Heart Disease: A Case Control Study

Abstract

Extracted data

Related items

Related items